<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36600349</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Prevalence of long COVID-19 among healthcare workers: a systematic review and meta-analysis protocol.</ArticleTitle><Pagination><StartPage>e065234</StartPage><MedlinePgn>e065234</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e065234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-065234</ELocationID><Abstract><AbstractText Label="INTRODUCTION">A proportion of those who survive the acute phase of COVID-19 experience prolonged symptoms, commonly known as long COVID-19. Given that healthcare workers (HCWs) face an elevated risk of acute COVID-19 compared with the general population, the global burden of long COVID-19 in HCWs is likely to be large; however, there is limited understanding of the prevalence of long COVID-19 in HCWs, or its symptoms and their clustering. This review will aim to estimate the pooled prevalence and the symptoms of long COVID-19 among HCWs infected with SARS-CoV-2 globally, and investigate differences by country, age, sex, ethnicity, vaccination status and occupation.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">A systematic review and meta-analysis will be conducted. Medline (via Ovid), CINAHL (via EBSCO), Embase (via Ovid), PsycINFO (via EBSCO), <i>OpenGrey</i> (grey literature) and <i>medRxiv</i> (preprint server) will be searched from the 31 December 2019 onward. All research studies and preprint articles reporting any primary data on the prevalence and/or the symptoms of long COVID-19 among adult HCWs will be included. Methodological quality will be assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data. Outcomes are anticipated to be the prevalence of long COVID-19 among HCWs around the world and trajectory of symptoms. Data synthesis will include random-effect meta-analysis for studies reporting prevalence data of long COVID-19 following SARS-CoV-2 infection among HCWs. The results will be presented with a 95% CI as an estimated effect across studies. Heterogeneity will be assessed using I&#xb2; statistic. Where meta-analysis is inappropriate, a narrative synthesis of the evidence will be conducted.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethical approval is not needed as data will be obtained from published articles. We will publish our findings in a peer-reviewed journal and disseminate the results of our review at conferences.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER">CRD42022312781.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Oraibi</LastName><ForeName>Amani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naidu</LastName><ForeName>Jatin Sridhar</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-9849-1976</Identifier><AffiliationInfo><Affiliation>Medical School, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaka</LastName><ForeName>Aasiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolf</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4915-0715</Identifier><AffiliationInfo><Affiliation>Medical School, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B Nellums</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2534-6951</Identifier><AffiliationInfo><Affiliation>Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarrant</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze</LastName><ForeName>Shirley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-2337-4799</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogoi</LastName><ForeName>Mayuri</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9946-2509</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazareth</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0603-9091</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pareek</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK manish.pareek@leicester.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection and HIV Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/V027549/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGY</Keyword><Keyword MajorTopicYN="N">PUBLIC HEALTH</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36600349</ArticleId><ArticleId IdType="pmc">PMC9729843</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-065234</ArticleId><ArticleId IdType="pii">bmjopen-2022-065234</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center . COVID-19 Map</Citation></Reference><Reference><Citation>NICE . COVID-19 rapid guideline: managing the long-term effects of COVID-19; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. . Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020;6:00542-2020. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS . Long-term effects of coronavirus (long COVID)</Citation></Reference><Reference><Citation>Han Q, Zheng B, Daines L, et al. . Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 2022;11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, Abdollahi A, et al. . Long COVID, a comprehensive systematic scoping review. Infection 2021;49:1163&#x2013;86. 10.1007/s15010-021-01666-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Long covid could be four different syndromes, review suggests. BMJ 2020;371:m3981. 10.1136/bmj.m3981</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3981</ArticleId><ArticleId IdType="pubmed">33055076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. . Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv 2021. 10.1101/2021.01.15.21249885</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.15.21249885</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275&#x2013;87. 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>The World Health Organization (WHO) . A clinical case definition of post COVID-19 condition by a Delphi consensus, 2021. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [Accessed 29 Nov 2021].</Citation></Reference><Reference><Citation>NICE . COVID-19 rapid guideline: managing the longterm effects of COVID-19, 2022. Available: https://www.nice.org.uk/guidance/ng188/resources/c</Citation></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. . 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021;9:747&#x2013;54. 10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Riyahi S, Dev H, Behzadi A, et al. . Pulmonary embolism in hospitalized patients with covid-19: a multicenter study. Radiology 2021;301:E426&#x2013;33. 10.1148/radiol.2021210777</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210777</ArticleId><ArticleId IdType="pmc">PMC8294351</ArticleId><ArticleId IdType="pubmed">34254850</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C, Tudoran M, Pop GN, et al. . Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2. Biology 2021;10:469. 10.3390/biology10060469</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10060469</ArticleId><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS) . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics [Internet], 2021. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7october2021 [Accessed 29 Nov 2021].</Citation></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021;27:1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan BW, Hwang AL, Ng F, et al. . Death toll of COVID-19 on Asian Americans: disparities revealed. J Gen Intern Med 2021;36:3545&#x2013;9. 10.1007/s11606-021-07003-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07003-0</ArticleId><ArticleId IdType="pmc">PMC8335981</ArticleId><ArticleId IdType="pubmed">34347256</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Why have black and South Asian people been hit hardest by COVID-19? 2020.</Citation></Reference><Reference><Citation>GOV.UK . Drivers of the higher COVID-19 incidence, morbidity and mortality among minority ethnic groups executive summary; 2020.</Citation></Reference><Reference><Citation>Eiros R, Barreiro-Perez M, Martin-Garcia A, et al. . Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv 2020. 10.1101/2020.07.12.20151316</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli F, Stampatori C, Righetti F, et al. . Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol 2021;268:4422&#x2013;8. 10.1007/s00415-021-10579-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10579-6</ArticleId><ArticleId IdType="pmc">PMC8088203</ArticleId><ArticleId IdType="pubmed">33932157</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte G, Favieri F, Tambelli R, et al. . COVID-19 pandemic in the Italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health 2020;17:4151&#x2013;16. 10.3390/ijerph17114151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17114151</ArticleId><ArticleId IdType="pmc">PMC7312976</ArticleId><ArticleId IdType="pubmed">32532077</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang HJ, Nan J, ZY L, et al. . Psychological impacts of the COVID-19 epidemic on Chinese people: exposure, post-traumatic stress symptom, and emotion regulation. Asian Pac J Trop Med 2020;13:252. 10.4103/1995-7645.281614</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1995-7645.281614</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CA, Pan D, Melbourne C, et al. . Predictors of SARS-CoV-2 infection in a multi-ethnic cohort of United Kingdom healthcare workers: a prospective nationwide cohort study (UK-REACH). medRxiv 2021. 10.1101/2021.12.16.21267934</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.16.21267934</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton-Roberts M, Runnels V, Rajan SI, et al. . Causes, consequences, and policy responses to the migration of health workers: key findings from India. Hum Resour Health 2017;15:1&#x2013;18. 10.1186/s12960-017-0199-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12960-017-0199-y</ArticleId><ArticleId IdType="pmc">PMC5382411</ArticleId><ArticleId IdType="pubmed">28381289</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M. PRISMA-P. Nurul Fatiha Risma, Nor Azmaniza &amp; Aniza. Advances Bus Res Int Journal 2021;196:224. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. . PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev 2021;10:1&#x2013;19. 10.1186/s13643-020-01542-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-020-01542-z</ArticleId><ArticleId IdType="pmc">PMC7839230</ArticleId><ArticleId IdType="pubmed">33499930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;sser SN. What Is a Validation Methodology? Analyzing and Synthesizing Two Meanings. In: Systemic management for intelligent organizations. Springer, 2012: 47&#x2013;60.</Citation></Reference><Reference><Citation>O'Connor AM, Anderson KM, Goodell CK, et al. . Conducting systematic reviews of intervention questions I: writing the review protocol, formulating the question and searching the literature. Zoonoses Public Health 2014;61 Suppl 1:28&#x2013;38. 10.1111/zph.12125</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/zph.12125</ArticleId><ArticleId IdType="pubmed">24905994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>